challenges and opportunities from a Pharma perspective Markus Gruber - PowerPoint PPT Presentation

Patent system of BRIC countries – challenges and opportunities from a Pharma perspective Markus Gruber & Denis Barbier, Principal Patent Attorneys, Novartis Pharma IP

Originator's Perspective Our personal views 2 | Patent system of BRIC countries| M. Gruber & D. Barbier| Swiss HLG Basel, 11 June 2014

A Wish List for Patent Systems in BRIC countries  IP plays an important role in providing the incentives necessary for the development and marketing of new medicines. An effective, transparent, and predictable IP system is necessary for both manufacturers of innovative medicines and manufacturers of generic medicines.  Common international standards for patentability, patent examination and enforcement  High quality patent examination leading to strong patents and a strong presumption of validity  Stronger interaction of examiners and judges on international level  Effective protection for clinical data  Availability of effective enforcement system including PIs or patent linkage systems 3 | Patent system of BRIC countries| M. Gruber & D. Barbier| Swiss HLG Basel, 11 June 2014

Pharma Patents Pharma Patents Obtention Enforcement BRAZIL _ + INDIA _ _ RUSSIA + _ CHINA + ( + ) SOUTH AFRICA ( + ) ( + ) 4 | Patent system of BRIC countries| M. Gruber & D. Barbier| Swiss HLG Basel, 11 June 2014

Thank you for your attention 5 | Patent system of BRIC countries| M. Gruber & D. Barbier| Swiss HLG Basel, 11 June 2014